Skip to main content

Table 5 KEEG enrichment and thalidomide

From: A framework to identify gene expression profiles in a model of inflammation induced by lipopolysaccharide after treatment with thalidomide

KEGGID

Pvalue

Count

Size

Term

4530

0.011

3

11

Tight junction

533

0.046

1

1

Keratan sulfate biosynthesis

604

0.046

1

1

Glycosphingolipid biosynthesis - ganglio series

1031

0.047

2

8

Glycan structures - biosynthesis 2

4620

0.047

2

8

Toll-like receptor signaling pathway

51

0.059

2

9

Fructose and mannose metabolism

4210

0.059

2

9

Apoptosis

3010

0.064

3

21

Ribosome

52

0.089

1

2

Galactose metabolism

512

0.089

1

2

O-Glycan biosynthesis

720

0.089

1

2

Reductive carboxylate cycle (CO2 fixation)

5213

0.089

1

2

Endometrial cancer

5218

0.089

1

2

Melanoma

5223

0.089

1

2

Non-small cell lung cancer

Back to article page